Astellas is a pharmaceutical company committed to turning innovation into value for patients. To accomplish this, we strive to create novel drugs and medical solutions, particularly in areas of high unmet need.

We work at the forefront of healthcare change in our key therapeutic areas of Oncology, Haematology, Urology, Transplant and Anti-Infectives, while advancing new therapeutic areas through discovery research and using new technologies. Our hope is to change tomorrow. To improve the lives of people in areas of health where there is urgent need for better treatments.

In 2006, Astellas made an enduring commitment to the field of Oncology, channelling our expertise in developing treatments to help meet the challenges faced by patients and their doctors. Since then, we have built a global Oncology R&D network and established collaborations with key organisations at the forefront of cancer research.

Date of preparation: January 2021

Document number: ONC_2021_0030_UK